Delivery Order SPE2DB20D1100-SPE2DB25FD5P7

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML medical products. The award has a ceiling value of $15,941.60 and a completion date of July 3, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor for this award, which is associated with...

This delivery order was awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc. for the provision of 4562584475 XOLAIR 75 MG/0.5 ML SYRINGE 0.5ML. The order has a potential value of two thousand three hundred twenty-one dollars and ten cents ($2,321.10) and is to be completed by November 13, 2023. It utilizes a firm fixed price contract type. No set-aside designation was applied. The place of performance will be Park Ridge, Illinois. The Defense Logistics...

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $7,704.50 firm fixed price contract is for the supply of XOLAIR 150 MG/ML autoinjectors. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, AmerisourceBergen provides a comprehensive range...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a pharmaceutical product, with a ceiling value of $3,188.32 and a period of performance through July 24, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML medication. The contract has a ceiling value of $3,188.32 and a period of performance ending on July 25, 2025. This contract is not set-aside and represents an open competition award. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, with a ceiling value of $1,712.23 and an ultimate completion date of June 13, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...

The Defense Logistics Agency awarded a $773 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4562235601 XOLAIR 150 MG/ML SYRINGEML, to be delivered by October 5, 2023. Xolair is the brand name for omalizumab, a prescription medicine that reduces the amount of antibody IgE in the blood. This delivery order was issued under an existing DLA pharmaceutical supply contract vehicle, with no set-aside designation specified. DMS Pharmaceutical...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of XOLAIR 300 MG/2 ML AUTOINJECT 2ML medication. The contract has a ceiling value of $3,188.32 and a period of performance through July 3, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a pharmaceutical product, with a ceiling value of $3,424.46 and a completion date of June 17, 2025. DMS Pharmaceutical Group Inc. is an established federal contractor, holding a significant single-award Indefinite Delivery Contract (IDC)...

This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of XOLAIR 150 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $9,245.40 and a completion date of May 21, 2024. The award is not associated with any set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office Division, is a major supplier of...